Nurix Therapeutics (NRIX) EBIT (QoQ) (2019 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) EBIT (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.85% |
| Feb 28, 2026 | -11.31% |
| Nov 30, 2025 | 9.07% |
| Aug 31, 2025 | -89.12% |
| May 31, 2025 | 23.13% |
| Feb 28, 2025 | 2.77% |
| Nov 30, 2024 | -18.40% |
| Aug 31, 2024 | -12.51% |
| May 31, 2024 | -7.34% |
| Feb 29, 2024 | 0.25% |
| Nov 30, 2023 | -13.30% |
| Aug 31, 2023 | -49.49% |
| May 31, 2023 | 37.69% |
| Feb 28, 2023 | 11.78% |
| Nov 30, 2022 | -4.22% |
| Aug 31, 2022 | -2.19% |
| May 31, 2022 | -6.95% |
| Feb 28, 2022 | -12.62% |
| Nov 30, 2021 | -30.89% |
| Aug 31, 2021 | -9.78% |